Cargando…
Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation
Nano-drugs based on nanoparticles (NP) or on nano-assemblies as carriers of the active pharmaceutical ingredient (API) are often expected to perform better compared to conventional dosage forms. Maximum realization of this potential though requires optimization of multiple physico-chemical, includin...
Autores principales: | Nordström, Rickard, Zhu, Lin, Härmark, Johan, Levi-Kalisman, Yael, Koren, Erez, Barenholz, Yechezkel, Levinton, Genia, Shamrakov, Dima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835975/ https://www.ncbi.nlm.nih.gov/pubmed/33478023 http://dx.doi.org/10.3390/pharmaceutics13010123 |
Ejemplares similares
-
Cardinal Role of Intraliposome Doxorubicin-Sulfate
Nanorod Crystal in Doxil Properties and Performance
por: Wei, Xiaohui, et al.
Publicado: (2018) -
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
por: Neun, Barry W., et al.
Publicado: (2018) -
Therapeutic Efficacy of Combining PEGylated Liposomal Doxorubicin and Radiofrequency (RF) Ablation: Comparison between Slow-Drug-Releasing, Non-Thermosensitive and Fast-Drug-Releasing, Thermosensitive Nano-Liposomes
por: Andriyanov, Alexander V., et al.
Publicado: (2014) -
Insights
into the Structure of Comirnaty Covid-19
Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles
with Hydrogen Bond-Stabilized mRNA–Lipid Complexes
por: Szebeni, János, et al.
Publicado: (2023) -
Specific Targeting of PEGylated Liposomal Doxorubicin (Doxil(®)) to Tumour Cells Using a Novel TIMP3 Peptide
por: Aldughaim, Mohammed S., et al.
Publicado: (2020)